Skip to main content

Advertisement

Log in

Platelet-Rich Plasma Injections: Pharmacological and Clinical Considerations in Pain Management

  • Regenerative Pain Medicine/Interventional Pain Medicine (E Cornett Bradley, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Regenerative medicine through interventional pain procedures is evolving with data demonstrating efficacy for a number of pain states in recent years. Platelet-rich plasma (PRP), defined as a sample of plasma with a platelet concentration 3 to 5 times greater than the physiologic platelet concentration found in healthy whole blood, releases bioactive proteins which can restore anatomical function in degenerative states. PRP is dense in growth factors, such as platelet-derived growth factor, transforming growth factor-beta1, basic fibroblastic growth factor, vascular endothelial growth factor, and epidermal growth factors.

Recent Findings

To date, well-designed case–control or cohort studies for the use of PRP have demonstrated efficacy in lumbar facet joint, lumbar epidural, and sacroiliac joint injections. At present, there is only level IV evidence indicating the need for larger and more carefully controlled prospective studies. PRP is utilized autogenously in order to facilitate healing and injection and has been studied in the long-term management of discogenic low back pain. In this regard, numerous studies have evaluated PRP to steroid injections in chronic pain states with favorable results.

Summary

PRP represents an opportunity for a new strategy in the therapeutic treatment of degenerative states of spines, joints, and other locations throughout the body with evolving data demonstrating both safety and long-term efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •   Of importance

  1. Hsu WK, Mishra A, Rodeo SR, Fu F, Terry MA, Randelli P, et al. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg. 2013;21(12):739–48.

    Article  Google Scholar 

  2. • Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21(20):7794. The article discusses the preparation and composition of PRP along with other pertinent points including drug interactions and rehabilitation protocols.

    Article  CAS  Google Scholar 

  3. Marx RE. Platelet-Rich Plasma (PRP): What is PRP and what is not PRP? Implant Dent. 2001;10(4):225–8.

    Article  CAS  Google Scholar 

  4. Knezevic NN, Candido KD, Desai R, Kaye AD. Is platelet-rich plasma a future therapy in pain management? Med Clin North Am. 2016;100(1):199–217.

    Article  Google Scholar 

  5. Kuffler D. Variables affecting the potential efficacy of PRP in providing chronic pain relief. J Pain Res. 2018;12:109–16.

    Article  Google Scholar 

  6. Cole BJ, Seroyer ST, Filardo G, Bajaj S, Fortier LA. Platelet-rich plasma: where are we now and where are we going? Sports Health Multidiscip Approach. 2010;2(3):203–10.

    Article  Google Scholar 

  7. • Le ADK, Enweze L, DeBaun MR, Dragoo JL. Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med. 2018;11(4):624–34. This review succinctly summarizes the level of evidence supporting PRP for different musculoskeletal indications.

    Article  Google Scholar 

  8. Cisternas MG, Murphy L, Sacks JJ, Solomon DH, Pasta DJ, Helmick CG. Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a US population-based survey: OA prevalence in a population-based survey. Arthritis Care Res. 2016;68(5):574–80.

    Article  Google Scholar 

  9. Sibille KT, Chen H, Bartley EJ, Riley J, Glover TL, King CD, et al. Accelerated aging in adults with knee osteoarthritis pain: consideration for frequency, intensity, time, and total pain sites. Pain Rep. 2017;2(3):e591.

    Article  Google Scholar 

  10. Torio CM, Moore BJ. National inpatient hospital costs: the most expensive conditions by payer, 2013: statistical brief #204. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 [cited 2021 Aug 1]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK368492/.

  11. Walker LC, Clement ND, Deehan DJ. Predicting the outcome of total knee arthroplasty using the WOMAC score: a review of the literature. J Knee Surg. 2019;32(08):736–41.

    Article  Google Scholar 

  12. Beswick AD, Wylde V, Gooberman-Hill R, Blom A, Dieppe P. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open. 2012;2(1):e000435.

    Article  Google Scholar 

  13. Cook CS, Smith PA. Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee. Curr Rev Musculoskelet Med. 2018;11(4):583–92.

    Article  Google Scholar 

  14. Martel-Pelletier J, Boileau C, Pelletier J-P, Roughley PJ. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol. 2008;22(2):351–84.

    Article  CAS  Google Scholar 

  15. Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014;5(3):351–61.

    Article  Google Scholar 

  16. Taniguchi Y, Yoshioka T, Kanamori A, Aoto K, Sugaya H, Yamazaki M. Intra-articular platelet-rich plasma (PRP) injections for treating knee pain associated with osteoarthritis of the knee in the Japanese population : a phase I and IIa clinical trial [Internet]. Nagoya University Graduate School of Medicine, School of Medicine; 2018 [cited 2021 Aug 1]. Available from: https://doi.org/10.18999/nagjms.80.1.39.

  17. Yaradilmis YU, Demirkale I, Tagral AS, Okkaoglu MC, Ates A, Altay M. Comparison of two platelet rich plasma formulations with viscosupplementation in treatment of moderate grade gonarthrosis: a prospective randomized controlled study. J Orthop. 2020;20:240–6.

    Article  Google Scholar 

  18. Elik H, Doğu B, Yılmaz F, Begoğlu FA, Kuran B. The efficiency of platelet-rich plasma treatment in patients with knee osteoarthritis. J Back Musculoskelet Rehabil. 2020;33(1):127–38.

    Article  Google Scholar 

  19. Greis PE, Bardana DD, Holmstrom MC, Burks RT. Meniscal injury: I. Basic science and evaluation. J Am Acad Orthop Surg. 2002;10(3):168–76.

    Article  Google Scholar 

  20. Everhart JS, Cavendish PA, Eikenberry A, Magnussen RA, Kaeding CC, Flanigan DC. Platelet-rich plasma reduces failure risk for isolated meniscal repairs but provides no benefit for meniscal repairs with anterior cruciate ligament reconstruction. Am J Sports Med. 2019;47(8):1789–96. https://doi.org/10.1177/0363546519852616.

    Article  PubMed  Google Scholar 

  21. Hoy D, Bain C, Williams G, March L, Brooks P, Blyth F, et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012;64(6):2028–37.

    Article  Google Scholar 

  22. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Lond Engl. 2016;388(10053):1603–58.

    Article  Google Scholar 

  23. Kaye AD, Manchikanti L, Abdi S, Atluri S, Bakshi S, Benyamin R, et al. Efficacy of epidural injections in managing chronic spinal pain: a best evidence synthesis. Pain Physician. 2015;18(6):E939-1004.

    Article  Google Scholar 

  24. Swain MS, Henschke N, Kamper SJ, Gobina I, Ottová-Jordan V, Maher CG. An international survey of pain in adolescents. BMC Public Health. 2014;14(1):447.

    Article  Google Scholar 

  25. Hestbaek L, Leboeuf-Yde C, Kyvik KO. Is comorbidity in adolescence a predictor for adult low back pain? A prospective study of a young population. BMC Musculoskelet Disord. 2006;7(1):29.

    Article  Google Scholar 

  26. DePalma MJ, Ketchum JM, Saullo T. What is the source of chronic low back pain and does age play a role? Pain Med. 2011;12(2):224–33.

    Article  Google Scholar 

  27. Levi D, Carnahan D, Horn S, Levin J. Is a history of severe episodic low back pain an indicator of a discogenic etiology? Pain Med. 2018;19(7):1334–9.

    Article  Google Scholar 

  28. Jain D, Goyal T, Verma N, Paswan AK, Dubey RK. Intradiscal platelet-rich plasma injection for discogenic low back pain and correlation with platelet concentration: a prospective clinical trial. Pain Med Malden Mass. 2020;21(11):2719–25.

    Article  Google Scholar 

  29. Xu Z, Wu S, Li X, Liu C, Fan S, Ma C. Ultrasound-guided transforaminal injections of platelet-rich plasma compared with steroid in lumbar disc herniation: a prospective, randomized, controlled study. Wang XQ, ed. Neural Plast. 2021;27(2021):1–11. https://doi.org/10.1155/2021/5558138.

    Google Scholar 

  30. Setayesh K, Villarreal A, Gottschalk A, Tokish JM, Choate WS. Treatment of muscle injuries with platelet-rich plasma: a review of the literature. Curr Rev Musculoskelet Med. 2018;11(4):635–42.

    Article  Google Scholar 

  31. Chen X, Jones IA, Park C, Vangsness CT. The efficacy of platelet-rich plasma on tendon and ligament healing: a systematic review and meta-analysis with bias assessment. Am J Sports Med. 2018;46(8):2020–32.

    Article  Google Scholar 

  32. Kearney RS, Ji C, Warwick J, Parsons N, Brown J, Harrison P, et al. Effect of platelet-rich plasma injection vs. sham injection on tendon dysfunction in patients with chronic midportion achilles tendinopathy: a randomized clinical trial. JAMA. 2021;326(2):137.

    Article  CAS  Google Scholar 

  33. Zicaro JP, Garcia-Mansilla I, Zuain A, Yacuzzi C, Costa-Paz M. Has platelet-rich plasma any role in partial tears of the anterior cruciate ligament? Prospective comparative study. World J Orthop. 2021;12(6):423–32.

    Article  Google Scholar 

  34. Malahias M-A, Roumeliotis L, Nikolaou VS, Chronopoulos E, Sourlas I, Babis GC. Platelet-rich plasma versus corticosteroid intra-articular injections for the treatment of trapeziometacarpal arthritis: a prospective randomized controlled clinical trial. Cartilage. 2021;12(1):51–61.

    Article  CAS  Google Scholar 

  35. Fricton J. Myogenous temporomandibular disorders: diagnostic and management considerations. Dent Clin North Am. 2007;51(1):61–83.

    Article  Google Scholar 

  36. Wright EF, North SL. Management and treatment of temporomandibular disorders: a clinical perspective. J Man Manip Ther. 2009;17(4):247–54.

    Article  Google Scholar 

  37. Chandra L, Goyal M, Srivastava D. Minimally invasive intraarticular platelet rich plasma injection for refractory temporomandibular joint dysfunction syndrome in comparison to arthrocentesis. J Fam Med Prim Care. 2021;10(1):254–8.

    Article  Google Scholar 

  38. Buchbinder R. Plantar fasciitis. N Engl J Med. 2004;350(21):2159–66.

    Article  CAS  Google Scholar 

  39. Peerbooms JC, Lodder P, den Oudsten BL, Doorgeest K, Schuller HM, Gosens T. Positive effect of platelet-rich plasma on pain in plantar fasciitis: a double-blind multicenter randomized controlled trial. Am J Sports Med. 2019;47(13):3238–46.

    Article  Google Scholar 

  40. Trull-Ahuir C, Sala D, Chismol-Abad J, Vila-Caballer M, Lisón JF. Efficacy of platelet-rich plasma as an adjuvant to surgical carpal ligament release: a prospective, randomized controlled clinical trial. Sci Rep. 2020;10(1):2085.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Audrey A. Grossen.

Ethics declarations

Ethics Approval and Consent to Participate

This article does not contain any studies with human or animal subjects performed by any of the authors.

Conflict of Interest

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Regenerative Pain Medicine/Interventional Pain Medicine

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grossen, A.A., Lee, B.J., Shi, H.H. et al. Platelet-Rich Plasma Injections: Pharmacological and Clinical Considerations in Pain Management. Curr Pain Headache Rep 26, 741–749 (2022). https://doi.org/10.1007/s11916-022-01082-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-022-01082-2

Keywords

Navigation